MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...
MSD (Merck & Co., Inc.) will vacate its laboratories at the Francis Crick Institute in London by end‑2025 as it winds down discovery research in the UK. The move follows the decision to scrap a ...
MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...
BDT & MSD Partners alum Adam Piekarski is starting anew and has formed Derby Lane Partners, a new real estate credit investment firm, according to a person with knowledge of the matter. New York-based ...
Eastdil Secured hired BDT & MSD Partners to advise the firm on potential strategic partnerships and growth initiatives, according to a memo seen by Bloomberg News. Eastdil said it’s tapping BDT & MSD ...
Hyderabad: US pharma giant Merck & Co Inc, which does business as Merck Sharp & Dohme (MSD) outside the United States and Canada, opened its first technology centre in India at Hyderabad this week, ...
“Runs good!” You’ve seen that a lot of times looking at Craigslist ads for cars and motorcycles, especially older ones. But what does that even mean? Why wouldn’t it “run good,” anyways Shouldn’t ...
BDT & MSD Partners proposes a 60-unit condominium at Boca Raton Resort & Club, amid a development frenzy for luxury projects in South Florida. The merchant bank, which has offices in New York and ...
Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and comes on ...
Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 people, ...
On December 28, The National Safety Council released the 2023-2024 MSD Solutions Index Pledge Community Report, which revealed progress in addressing one of the most pervasive workplace injuries: ...